申请演示

Press Release - MIMneuro 5.5

MIM Software releases MIMneuro 5.5 featuring Quantitative Analysis of Amyloid Images

Cleveland, Ohio – July 23, 2012 – MIM Software Inc. a leading global provider of medical imaging software, announced today that the 5.5 version of MIMneuro® is now available.

MIMneuro 5.5 includes three new enhancements that make it particularly well-suited for quantitative analysis of amyloid PET images.

Traditionally, the variability in uptake patterns with targeted tracers such as amyloid PET agents have confounded single template registration approaches. But now, the MIMTM BrainAlignTM deformable registration algorithm includes the ability to deformably register to multiple templates simultaneously. With this landmark-based deformable registration approach, local differences in anatomy can be resolved more accurately than with affine registration or other deformable registration approaches.

Secondly, MIM SoftwareTM has worked with experts in the field to define and release a third anatomical brain atlas. This probabilistic amyloid atlas is a tool specifically tuned for performing quantitative regional analysis on amyloid PET images.

Finally, a database of healthy controls has been integrated for statistical analysis of amyloid PET images.

MIMneuro 5.5 combines these three new features with existing tools for statistical comparisons – including voxel-based analysis, region-based analysis, SUVR computation, cluster analysis, and surface projection analysis – into the most comprehensive quantitative functional neuroimaging software on the market.

Interested users should contact MIM Software at 866-421-2536 for a demo.
Qualified existing MIMneuro users can upgrade to version 5.5 now.

For more information, e-mail info@mimsoftware.com.

MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac® workstations, as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.